Patients with primary ICH and who underwent MRI, including DWI sequences ≤14 days from symptom onset, were included. All known or suspected causes of secondary ICH, such as vascular malformations, structural lesions, trauma, or hemorrhagic transformation of an ischemic infarct, were excluded. The research protocol was approved for waiver of consent by our local Human Research Ethics Board.
P rimary intracerebral hemorrhage (ICH) is associated with high morbidity and mortality. Baseline hematoma volume, 1 hematoma expansion, 2 and high blood pressure (BP) 3 are associated with poor outcome. The Intensive Reduction of Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials (INTERACT and INTERACT II) have shown that aggressive BP reduction (<140 mm Hg) in ICH is associated with decreased hematoma growth at 24 hours and better functional outcomes. 4, 5 Despite this, the possibility of ischemic injury, both within the perihematoma region and remote from the hematoma remains a concern. Although few cases of clinically evident ischemic stroke were seen in either INTERACT trial, several magnetic resonance imaging (MRI) studies indicate subacute ischemic injury after ICH is relatively common. [6] [7] [8] [9] [10] [11] The primary aim of this study was to identify the frequency of perihematoma and remote MRI ischemic lesions in primary ICH patients. We also aimed to determine whether acute BP change over the first 24 hours was associated with ischemic injury. We tested the hypotheses that larger ICH volumes and BP reduction are associated with DWI lesions.
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review. The maximal SBP drop in 24 hours was calculated as admission SBP minus nadir SBP within the first 24 hours. The weighted average BP was calculated as the area under the curve of SBP, DBP, and MAP over 24 hours.
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Imaging Analyses
All available neuroimaging, including computed tomography, MRI, and vascular studies, were reviewed. Patients were imaged using either a single or 8-channel phased array radiofrequency head coil on a 1.5-T whole-body Siemens Sonata MRI scanner. The MRI protocol consisted of axial T1-and T2-weighted images, gradient-recalled echo or susceptibility-weighted imaging, fluid-attenuated inversion recovery, and DWI sequences. All planimetric analyses were performed using Analyze 11.0 (Biomedical Imaging Resource, Mayo Clinic, Rochester, NY). 13 Hematoma volumes were measured on noncontrast computed tomography scan images using semiautomatic threshold-based segmentation techniques. The boundaries of the hematoma and perihematoma edema regions on MRI were outlined manually, based on consensus between 3 authors (L.C. Gioia, M. Kate, K. Butcher), on baseline DWI (b=0; no diffusion gradients applied) images as described previously.
14 Region-of-interest object maps were coregistered to apparent diffusion coefficient (ADC) maps to obtain the absolute ADC values within the perihematoma edematous region. Perihematoma edema volumes were calculated as the tissue volume with an ADC >965×10 −6 mm2/s within the visibly edematous region. This threshold was based on the mean and standard deviation of the ADC within the edematous region reported previously, 14 as well as the reported upper ADC of normal appearing white matter (960×10 −6 mm 2 /s). [15] [16] [17] Relative ADC was calculated as the ratio of the absolute perihematoma ADC to that in contralateral homologous regions. ADC thresholds for moderate ischemia (730×10 −6 mm/s) and severe ischemia (550×10 −6 mm/s) were applied within the visibly edematous perihematoma region as described previously. 18 Areas with high signal on DWI (b=1000) images and corresponding low ADC both within the perihematoma region and remote from the hematoma were manually outlined.
Cerebral microbleeds were counted using either gradient-recalled echo or susceptibility-weighted imaging sequences (whichever was available) and classified by anatomic location (lobar/deep/infratentorial) according to the Brain Observer MicroBleed Scale scale. 19 The presence of any previous ICH identified on gradient-recalled echo/ susceptibility-weighted imaging (whether symptomatic or not) was also recorded. Leukoariaosis was identified as hyperintensities on fluid-attenuated inversion recovery sequences and leukoariaosis volumes were measured using semiautomatic thresholding segmentation techniques. Leukoariosis severity was graded according to the Fazekas scale.
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Statistical Analyses
All statistical analyses were performed using the Statistical Package for Social Sciences version 21.0.0 (IBM SPSS Statistics Inc, 2013, Armonk, NY). Differences in baseline patient characteristics and imaging data between patients with and without DWI lesions were assessed using independent t-tests or Mann-Whitney tests for parametric and nonparametric data, respectively. Pearson Chi-square or Fisher's exact tests were used to compare the frequencies of clinical and imaging characteristics between patients with and without DWI lesions. Spearman's rank correlations test was used to assess the correlation between perihematoma tissue volumes reaching ischemic thresholds and hematoma volumes. Volume data were subsequently log-transformed for univariate and multivariate linear regression analyses. Inter-rater reliability was estimated using intraclass correlation coefficients between 2 raters for hematoma and leukoariaosis volumes.
Results
One hundred and seventeen patients met the inclusion criteria. Sixty-two patients with primary ICH and MRI were excluded from analyses as a result of MRI performed without DWI sequences (n=47), MRI performed >14 days after onset (n=14), or decompressive hemicraniectomy performed before MRI (n=1). The mean age was 65.6±13.0 years, and 52.1% of patients were male. The median (interquartile range) Glasgow Coma Scale (GCS) score was 15 (14) (15) and the median National Institutes of Health Stroke Scale score was 5 (2-11). Sixty-five percent of patients had a previous history of hypertension (44.4% were taking antihypertensive therapy), 4.3% had a previous ischemic stroke, and 5.1% had a previous ICH. The ICH was associated with antiplatelet or anticoagulant use in 24.8% and 8.5% of patients, respectively.
Forty-four percent of bleeds were lobar in location, 41.0% were deep, and 15.4% were infratentorial. Hypertension was the most common cause of ICH (45.7%), and probable/possible amyloid angiopathy was considered to be the cause in 11 (9.4%) patients. A total of 10 (8.5%) cases were considered to be anticoagulant-associated ICH. The cause of ICH was unknown in 36.4% of patients. The median hematoma volume, measured on computed tomography scan, was 9.8 (2.6-23.0) mL (range 0.5-113.8 mL). Inter-rater agreement for hematoma volumes was excellent (intraclass correlation coefficients 0.96). The median time to diagnostic computed tomography scan was 2.8 (1.5-7.8) hours.
Perihematoma DWI Lesions
The median (interquartile range) time to MRI was 2 (1-5) days. The median perihematoma edema volume was 7.0 (2.9-18.6) mL with a mean absolute ADC value of 1260±117.3×10 −6 mm2/s. The mean relative ADC value was 1.47±0.18 and perihematoma relative ADC values were ≥1.1 in all patients.
The median (interquartile range) volume of tissue below the threshold for moderate ischemia was 0.7 (0.3-2.0) mL, which represented 8.0 (2.9-14.5)% of tissue within the perihematoma edematous region. The median volume of perihematoma tissue reaching severe ischemic thresholds was 0.13 (0.04-0.5) mL (1.1 [0.3-3.5]%). Focal areas of diffusion restriction within the perihematoma region were visible in 38 patients (32.4%), with a median volume of 1.3 (0.5-4.0) mL. The mean ADC in this tissue was 630.5±76.0×10 −6 mm2/s ( Figure 1 ). The volume of visually apparent perihematoma DWI lesions was directly correlated with the volume of tissue reaching both moderate (R=0.72, P<0.001) and severe (R=0.80, P<0.001) ischemic thresholds.
Patients with perihematoma DWI lesions had higher baseline National Institutes of Health Stroke Scale scores, larger hematoma and perihematoma edema volumes, and higher rates of subarachnoid extension than those who did not (Table 1) . Both hematoma and perihematoma volumes reaching ischemic thresholds were log-transformed for further analyses. The volume of perihematoma tissue with ADC below the thresholds for both moderate (R=0.53, β=0.62, P<0.001) and severe ischemia (R=0.56, β=0.69, P<0.001) was correlated with hematoma volumes (Figure 2 ). The total volume of visible DWI lesions was also correlated with hematoma volume (R=0.54, β=0.54, P<0.001). In a multivariable linear regression model adjusting for age, baseline National Institutes of Health Stroke Scale scores, and perihematoma edema volumes, hematoma volume remained the only independent 
Remote DWI Lesions
A total of 42 DWI lesions remote from the hematoma/perihematoma region were found in 17 patients (range 1-6 lesions/ patient; 14.5% prevalence). The mean volume of remote DWI lesions was 0.44±0.3 mL. Fifty percent of remote DWI lesions were cortical in location, while the remainder were subcortical with the exception of 1 infratentorial lesion. Remote DWI lesions in 11 patients (66%) were located in the hemisphere contralateral to the hematoma. Three patients with DWI lesions underwent cerebral angiography before MRI and were excluded from further analyses.
Baseline clinical characteristics were similar between patients with and without remote DWI lesions, with the exception of higher rates of antiplatelet and antihypertensive drug use in patients with remote DWI lesions ( 
Blood Pressure Treatment and DWI Lesion Development
BP data were available in 103/117 patients (88.0%). Fourteen patients were excluded from BP analysis because of late hospital arrival (symptom onset or last time seen well ≥24 hours; n=10) or transfer from another hospital without accompanying BP documentation (n=4). All patients with remote DWI lesions and 34 of 38 patients (89.5%) with perihematoma DWI lesions had available 24-hour BP data.
Mean admission SBP was similar in patients with (166.7±30.9 mm Hg) and without DWI lesions in any location Figure 3B ). The volume of perihematoma tissue reaching ischemic thresholds was not correlated with the maximal SBP drop at 24 hours (R=−0.1, P=0.38; Figure 3C ). Weighted average BPs over the first 6 hours and 24 hours were similar in patients with and without DWI lesions ( Figure 3D ). Rates of intravenous antihypertensive drug administration were not different between patients with/without perihematoma (38.8% versus 31.6%, P=0.24) or remote DWI lesions (35.7% versus 32%, P=0.30).
Discussion
In a large sample of patients with primary ICH using objective ADC thresholds, we showed that small volumes of tissue reaching moderate and severe ischemic thresholds are Figure 1 . Examples of diffusion-weighted imaging (DWI) lesions in the perihematoma region and more remotely in patients with intracerebral hemorrhage (ICH). A, Perihematoma DWI lesions as seen on DWI b=0 and b=1000 sequences and apparent diffusion coefficient (ADC) maps with corresponding regions of interest (red, hematoma boundary; white, perihematoma edema boundary). High intensity on DWI b=1000 and low ADC values (depicted in blue) represent diffusion restriction. B, Examples of DWI lesions in regions remote to the perihematoma region as seen on DWI b0, b1000, and ADC maps.
by guest on July 14, 2017 http://stroke.ahajournals.org/ Downloaded from present both within and outside the perihematoma region. Perihematoma DWI lesions were independently predicted by larger ICH volumes. DWI lesions remote from the perihematoma region were associated with higher leukoaraiosis volumes, prior antiplatelet and antihypertensive use, prior ICH, and lobar ICH location. We found no relationship between any measure of BP reduction during the first 24 hours and DWI lesion development in any location.
Our study is consistent with previous studies describing perihematoma diffusion restriction after ICH. Limited areas of bioenergetic compromise within the perihematoma region have been described in 22% to 61% of patients within the first 6 hours of ICH. [16] [17] [18] However, these studies had relatively small sample sizes (n=12-32) and sometimes included ICH with secondary etiologies, including hemorrhagic transformation of ischemic stroke and vascular malformations. Our results confirm that although the perihematoma region consists primarily of tissue with elevated ADC values, consistent with vasogenic edema, a small amount of perihematoma tissue reaching ischemic ADC thresholds is present. Furthermore, the probability of diffusion restriction is strongly correlated with hematoma volume.
It is unknown if perihematoma diffusion restriction represents true ischemic injury, presumably related to microvascular compromise, or bioenergetic compromise secondary to mechanical compression of the tissue, or neurotoxicity related to hematoma formation and degradation. 21 Certainly, the correlation between hematoma volume and diffusion restriction is compatible with all 3 of these hypotheses. The ischemic hypothesis is most relevant to patient management, because of the implications for BP treatment.
In our study, we found no relationship between baseline BP, change in BP, or control of BP over the initial 24 hours and the subsequent development of perihematoma DWI lesions. This is consistent with the results of a recent randomized controlled trial of 2 BP treatment targets demonstrating that perihematoma hypoperfusion is not exacerbated by acute BP reduction. 22 Nonetheless, we cannot exclude the possibility that perihematoma DWI lesions are related to aggressive BP reduction. One potential implication may be that larger hematomas should be treated more conservatively with respect to BP reduction, but this requires verification in larger clinical studies.
More recent MRI studies have raised concerns related to subacute ischemic injury in regions remote from the hematoma. [6] [7] [8] [9] [10] [11] Among various variables shown to be associated with DWI lesions, the most concerning is the association with BP lowering. 6, 7, 11 Garg et al completed a relatively large study (n=95), where remote DWI lesions were seen in 41% of patients. They showed that patients with DWI lesions had a greater mean Figure 2 . Relationship between perihematoma tissue volumes reaching ischemic thresholds and hematoma volume. Correlation coefficients calculated using Spearman rank correlation. decrease from baseline BP values within 96 hours from symptom onset. 11 In our study, we did not find an association between remote DWI lesions and any measure of BP change or control over the first 24 hours. This may be related to the relatively modest decrease in BP over 24 hours in our patients. Given that admission SBP was below the current guideline-recommended target for BP reduction (<180 mm Hg) in a significant proportion of patients in our study, it is possible that some patients were less likely to receive aggressive BP treatment. We have previously shown that BP targets are rarely achieved in a timely fashion in patients treated outside of clinical trials. 23 Indeed, we found median SBP changes over 24 hours ranged from −5 to −35 mm Hg, in contrast to the more precipitous drop (−55 to −70 mm Hg) seen in patients with DWI lesions in Garg et al. Thus, it is possible that a larger decline in SBP is associated with higher rates of acute DWI lesion formation. Two other studies reported an association between mean arterial pressure decline >40% and DWI lesion formation. 6, 7 However, these results were based on BP values obtained at few time points (baseline, lowest to highest values before MRI and BP at 1 month) and therefore may not reflect true BP control during the acute phase of ICH. In our study, we included several time points within the first 24 hours after ICH, a period where BP change is the most dramatic. Furthermore, we attempted to assess global BP control over 24 hours by assessing the weighted average BP over 24 hours.
Nonetheless, the relationship between BP reduction and DWI lesion formation can only be effectively addressed using a randomized trial design and an MRI end point. In addition to differences in DWI lesion frequency with respect to BP targets, it may be of interest to analyze the relationship between the likelihood of DWI lesion development and the magnitude of BP drop over time in ongoing and future trials.
The pathogenesis of remote DWI lesions in subacute ICH remains unknown. We found correlations between remote DWI lesion and previous antiplatelet use, antihypertensive use, and leukoaraiosis volumes, which is consistent with previous investigations. 8, 9 These findings suggest that an underlying microangiopathy may play a role in DWI lesion formation in ICH. An ischemic stroke-prone prothombotic state in ICH has been previously hypothesized. 24 Antiplatelet withdrawal at the time of ICH presentation may contribute to remote DWI lesion formation, particularly in the presence of an underlying vasculopathy.
The fact that patients with remote DWI lesions had higher rates of prior ICH and lobar ICH location also raises the possibility that these are related to amyloid angiopathy. Indeed, previous studies have demonstrated an association between DWI lesions and cerebral microbleed burden.
8,10 Although we did not find an association between DWI lesions and cerebral microbleeds, our relatively small study with heterogenous T2* imaging for microbleed detection (susceptibility-weighted imaging and gradient-recalled echo) certainly does not exclude a relationship between the 2.
Finally, we did observe potential embolic sources in several patients with remote DWI lesions. Three patients with remote DWI lesions underwent cerebral angiography before MRI. Distal embolization is a known complication of cerebral angiography, which is often included in the etiologic workup of ICH. Although such patients were excluded from our predictive modeling analyses, they are part of the spectrum of etiologies which may be associated with DWI lesion formation in ICH. Cardioembolic sources of DWI lesion formation are also possible in ICH. In our study, we observed a trend between a diagnosis of atrial fibrillation and remote DWI lesions. Given that paroxysmal atrial fibrillation is found in ≈25% of patients >85 years of age and oral anticoagulation is sometimes associated with ICH, including 8.5% of our patients, a cardioembolic source is a plausible mechanism of DWI lesion development in at least some ICH patients. Hence, all potential sources of embolization need to be considered in ICH patients with DWI lesions.
Because of its retrospective design, selection bias is possible in our patient population. Indeed, there is a higher than expected proportion of lobar ICH in our sample, reflecting the fact these patients are more likely to undergo MR imaging to rule out a secondary cause of ICH. Similarly, patients with early declaration of poor prognosis and withdrawal of care were systematically excluded from our study. It is possible that perihematoma and remote DWI lesions are even more common in these patients, most of whom would have larger hematoma volumes. Furthermore, BP analysis was limited to the clinical data recorded, and ideally, shorter intervals between BP measurements would better represent BP changes in the first 24 hours. Nevertheless, our study included more time points in the acute phase of ICH than previous studies. Finally, it is possible that variable time to MRI may have resulted in an underestimation of the frequency of remote and perihematoma DWI lesions, particularly at later imaging time points (>7 days) because most DWI lesions are small and may not result in visible permanent T2/fluid-attenuated inversion recovery lesions once they resolve.
Conclusions
Small ischemic lesions are common in the perihematoma region and remote from the hematoma in patients with primary ICH. DWI lesion formation in ICH seems to be multifactorial, including the effects of the hematoma itself, the presence of an underlying microangiopathy (hypertensive and amyloid), or possibly sources of distal embolization. We could find no relationship between BP reduction in the first 24 hours and DWI lesion formation in any location. These data do not support a hemodynamic pathogenesis of DWI lesion development. Nonetheless, a randomized study with an MRI end point will be needed to definitively determine whether BP reduction is causally related to ischemic lesion development after ICH. 
